Literature DB >> 26289612

Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

Cibele S Pinto1, Archana Raman2, Gail A Reif1, Brenda S Magenheimer3, Corey White1, James P Calvet3, Darren P Wallace4.   

Abstract

cAMP stimulates cell proliferation and Cl(-)-dependent fluid secretion, promoting the progressive enlargement of renal cysts in autosomal dominant polycystic kidney disease (ADPKD). Intracellular cAMP levels are determined by the balance of cAMP synthesis by adenylyl cyclases and degradation by phosphodiesterases (PDEs). Therefore, PDE isoform expression and activity strongly influence global and compartmentalized cAMP levels. We report here that PDE3 and PDE4 expression levels are lower in human ADPKD tissue and cells compared with those of normal human kidneys (NHKs), whereas PDE1 levels are not significantly different. Inhibition of PDE4 caused a greater increase in basal and vasopressin (AVP)-stimulated cAMP levels and Cl(-) secretion by ADPKD cells than inhibition of PDE1, and inhibition of PDE4 induced cyst-like dilations in cultured mouse Pkd1(-/-) embryonic kidneys. In contrast, inhibition of PDE1 caused greater stimulation of extracellular signal-regulated kinase (ERK) and proliferation of ADPKD cells than inhibition of PDE4, and inhibition of PDE1 enhanced AVP-induced ERK activation. Notably, inhibition of PDE1, the only family of Ca(2+)-regulated PDEs, also induced a mitogenic response to AVP in NHK cells, similar to the effect of restricting intracellular Ca(2+). PDE1 coimmunoprecipitated with B-Raf and A-kinase anchoring protein 79, and AVP increased this interaction in ADPKD but not NHK cells. These data suggest that whereas PDE4 is the major PDE isoform involved in the regulation of global intracellular cAMP and Cl(-) secretion, PDE1 specifically affects the cAMP signal to the B-Raf/MEK/ERK pathway and regulates AVP-induced proliferation of ADPKD cells.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  AVP; cyclic AMP; cyclic GMP; epithelial cell; polycystic kidney disease; proliferation; renal

Mesh:

Substances:

Year:  2015        PMID: 26289612      PMCID: PMC4814181          DOI: 10.1681/ASN.2015010047

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  57 in total

Review 1.  AKAP79 and the evolution of the AKAP model.

Authors:  K Dodge; J D Scott
Journal:  FEBS Lett       Date:  2000-06-30       Impact factor: 4.124

Review 2.  Tissue specificity and physiological relevance of various isoforms of adenylyl cyclase.

Authors:  N Defer; M Best-Belpomme; J Hanoune
Journal:  Am J Physiol Renal Physiol       Date:  2000-09

3.  cAMP-dependent fluid secretion in rat inner medullary collecting ducts.

Authors:  D P Wallace; L A Rome; L P Sullivan; J J Grantham
Journal:  Am J Physiol Renal Physiol       Date:  2001-06

Review 4.  Polycystins: from mechanosensation to gene regulation.

Authors:  Patrick Delmas
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

Review 5.  The genetics and physiology of polycystic kidney disease.

Authors:  J P Calvet; J J Grantham
Journal:  Semin Nephrol       Date:  2001-03       Impact factor: 5.299

Review 6.  Regulation and role of adenylyl cyclase isoforms.

Authors:  J Hanoune; N Defer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

7.  Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.

Authors:  K Hanaoka; F Qian; A Boletta; A K Bhunia; K Piontek; L Tsiokas; V P Sukhatme; W B Guggino; G G Germino
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

8.  The cytoplasmic C-terminal fragment of polycystin-1 regulates a Ca2+-permeable cation channel.

Authors:  D H Vandorpe; M N Chernova; L Jiang; L K Sellin; S Wilhelm; A K Stuart-Tilley; G Walz; S L Alper
Journal:  J Biol Chem       Date:  2000-10-23       Impact factor: 5.157

Review 9.  Cyclic nucleotide phosphodiesterases: relating structure and function.

Authors:  S H Francis; I V Turko; J D Corbin
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2001

10.  cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.

Authors:  T Yamaguchi; J C Pelling; N T Ramaswamy; J W Eppler; D P Wallace; S Nagao; L A Rome; L P Sullivan; J J Grantham
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

View more
  18 in total

1.  Fundamental insights into autosomal dominant polycystic kidney disease from human-based cell models.

Authors:  Caroline Weydert; Jean-Paul Decuypere; Humbert De Smedt; Peter Janssens; Rudi Vennekens; Djalila Mekahli
Journal:  Pediatr Nephrol       Date:  2018-09-13       Impact factor: 3.714

2.  Integrin-Linked Kinase Signaling Promotes Cyst Growth and Fibrosis in Polycystic Kidney Disease.

Authors:  Archana Raman; Gail A Reif; Yuqiao Dai; Aditi Khanna; Xiaogang Li; Lindsay Astleford; Stephen C Parnell; James P Calvet; Darren P Wallace
Journal:  J Am Soc Nephrol       Date:  2017-05-18       Impact factor: 10.121

3.  Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.

Authors:  Linda Xiaoyan Li; Lucy X Fan; Julie Xia Zhou; Jared J Grantham; James P Calvet; Julien Sage; Xiaogang Li
Journal:  J Clin Invest       Date:  2017-06-12       Impact factor: 14.808

4.  B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease.

Authors:  Sara J Holditch; Claire A Schreiber; Peter C Harris; Nicholas F LaRusso; Marina Ramirez-Alvarado; Alessandro Cataliotti; Vicente E Torres; Yasuhiro Ikeda
Journal:  Kidney Int       Date:  2017-04-14       Impact factor: 10.612

5.  Deficient transient receptor potential vanilloid type 4 function contributes to compromised [Ca2+]i homeostasis in human autosomal-dominant polycystic kidney disease cells.

Authors:  Viktor Tomilin; Gail A Reif; Oleg Zaika; Darren P Wallace; Oleh Pochynyuk
Journal:  FASEB J       Date:  2018-03-19       Impact factor: 5.191

6.  PKD1-Dependent Renal Cystogenesis in Human Induced Pluripotent Stem Cell-Derived Ureteric Bud/Collecting Duct Organoids.

Authors:  Shohei Kuraoka; Shunsuke Tanigawa; Atsuhiro Taguchi; Akitsu Hotta; Hitoshi Nakazato; Kenji Osafune; Akio Kobayashi; Ryuichi Nishinakamura
Journal:  J Am Soc Nephrol       Date:  2020-08-03       Impact factor: 10.121

Review 7.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

Review 8.  Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities.

Authors:  Arun Samidurai; Lei Xi; Anindita Das; Audra N Iness; Navin G Vigneshwar; Pin-Lan Li; Dinender K Singla; Sakthivel Muniyan; Surinder K Batra; Rakesh C Kukreja
Journal:  Pharmacol Ther       Date:  2021-04-22       Impact factor: 13.400

9.  Vasopressin-related copeptin is a novel predictor of early endothelial dysfunction in patients with adult polycystic kidney disease.

Authors:  Ismail Kocyigit; Mahmut Ilker Yilmaz; Ozkan Gungor; Eray Eroglu; Aydin Unal; Ozcan Orscelik; Bulent Tokgoz; Murat Sipahioglu; Ahmet Sen; Juan Jesús Carrero; Oktay Oymak; Jonas Axelsson
Journal:  BMC Nephrol       Date:  2016-11-30       Impact factor: 2.388

10.  Generation and phenotypic characterization of Pde1a mutant mice.

Authors:  Xiaofang Wang; Satsuki Yamada; Wells B LaRiviere; Hong Ye; Jason L Bakeberg; María V Irazabal; Fouad T Chebib; Jan van Deursen; Peter C Harris; Caroline R Sussman; Atta Behfar; Christopher J Ward; Vicente E Torres
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.